£124.86

The Law of Off-label Uses of Medicines: Regulation and Litigation in the EU, UK and USA

Law

Price data last checked 152 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£125 today · usual range £0–£0 · best ever £97

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 579 days • 579 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 579 days • 5 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £111-119 (200 days, 34.5%)

Price range: £97 - £133

Price levels: 5 price ranges over 579 days

Description

This book examines the regulatory framework for untested and unapproved uses (off-label uses) of medicines in the EU, UK, and USA. Before reaching patients, medicines are extensively tested by manufacturers and approved by regulators to minimise the risk of adverse reactions. However, physicians can prescribe pharmaceuticals for off-label uses, widespread in paediatrics, oncology, rare diseases and, more recently, in treatment for Covid-19. While off-label uses may offer hope, they may also expose patients to risks and uncertainties. Clarification is therefore needed to improve the protection of patients' rights while enhancing legal certainty for health actors. To this end, this work clarifies the regulatory mechanisms and litigation trends concerning off-licence prescriptions in these jurisdictions. It assesses how traditional, prevention-driven regulatory and civil liability rules are being adapted to tackle potential risks and scientific uncertainty. The book outlines the applicable regulations, as well as considering Brexit’s impact on off-label policies in the UK, and EU and national off-label policies in the context of the fight against the Covid-19 pandemic. It also explores under what conditions physicians, manufacturers, or regulators must compensate patients injured by untested prescriptions. The book will be an essential resource for researchers, academics and policy-makers working in the areas of medical law and ethics, public health law, pharmaceutical law and private comparative law.

Product Specifications

Format: hardcover
ASIN: 1032078987
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 12 August 2022
Listed Since: 21 February 2022

Barcode

No barcode data available

The Law of Off-label Uses of Medicines: Regulation and Litigation in the EU, UK and USA

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Guide to EU and UK Pharmaceutical Regulatory Law

Medicines, Medical Devices and the Law

Medicines, Medical Devices and the Law

Guide to EU Pharmaceutical Regulatory Law

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Global Issues in Pharmaceutical Marketing

Pharmaceutical and Medical Device Safety: A Study in Public and Private Regulation (Civil Justice Systems)

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Illicit Medicines in the Global South: Public Health Access and Pharmaceutical Regulation (Routledge Global Health Series)

Pharmaceuticals, Corporate Crime and Public Health

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law)

The Pharmaceutical Industry: A Guide to Historical Records (Studies in British Business Archives)

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research

Drug Information: A Guide for Pharmacists, Fourth Edition

Springer - Innovation and Marketing in Pharmaceutical Industry

Neoliberalism, State-Corporate Power and Regulatory Failure: The Harms of Prescription and Non-Prescription Medicine Regulation in Australia (Routledge Studies in Crime and Society)

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)